glp-1 regulatory news Zydus' Drug Development Halted by Hurdles | OneAlphaMed posted on the topic The New York Times spotlighted

The hormone has become more well-known as GLP-1 agonist and GLP1-GIP receptor medications, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), have become prescribed more often

[1][2][3] More specifically, its benefits appear to include [3],[4],[5],[6]: Reduction in body weight Reduction in Body Mass Index (BMI) Reduction in fat mass Reduction in hip circumference and waist circumference Reduction in total and LDL cholesterol Reduction in triglycerides Increase in good HDL cholesterol This is particularly true for individuals with excess body weight , especially when L-carnitine is combined with regular exercise

Pork, chicken & poultry, and fish contain L-Carnitine but less than red meat

Zinc transporters ZnT3 and ZnT6 are downregulated in the spinal cords of patients with sporadic amyotrophic lateral sclerosis